LSTA
LISATA THERAPEUTICS, INC.
Key Financials
Gross Profit
$1.7M
↓ 27.7%
Net Income
$-16586000
↑ 17.0%
Operating Income
$-18209000
↑ 18.7%
Revenue
$170000
↓ 83.0%
EPS (Diluted)
$-1.91
↑ 20.4%
Total Liabilities
$3.1M
↓ 44.7%
Shareholders' Equity
$14.9M
↓ 49.8%
Cash & Equivalents
$16.0M
↓ 1.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/11/2026 | View on SEC |
| SC TO-C | 5/4/2026 | View on SEC |
| SC14D9C | 5/4/2026 | View on SEC |
| 8-K | 5/4/2026 | View on SEC |
| 10-K/A | 4/28/2026 | View on SEC |
| SC14D9C | 4/15/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| SC14D9C | 4/3/2026 | View on SEC |
| 8-K | 4/3/2026 | View on SEC |
| 10-K | 3/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LSTA |
| Company Name | LISATA THERAPEUTICS, INC. |
| CIK | 320017 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 908-229-2590 |